Search results

NICE has developed a medtech innovation briefing (MIB) on the Neo Pedicle Screw System for spinal fusion surgery .

Result type

Medtech innovation briefing

Published

13 June 2017

Evidence-based recommendations on arsenic trioxide (Trisenox) for treating acute promyelocytic leukaemia in adults.

Result type

Technology appraisal guidance

Published

13 June 2018

well-established systems for the assessment of mental states, in primary and secondary care services, for common mental...

Result type

Research recommendation

Published

9 June 2015

Evidence-based recommendations on nintedanib for treating progressive fibrosing interstitial lung diseases in adults.

Result type

Technology appraisal guidance

Published

17 November 2021

notes(if applicable) Why this is important:- As a gluten-free diet is the primary treatment option for people with coeliac disease, it...

Result type

Research recommendation

Published

13 October 2015

Evidence-based recommendations on tirzepatide (Mounjaro) for type 2 diabetes in adults.

Result type

Technology appraisal guidance

Last updated

1 September 2025

This guidance has been updated and replaced by NICE guideline CG185.

Result type

Withdrawn guideline

NICE has developed a medtech innovation briefing (MIB) on the Otovent nasal balloon for otitis media with effusion

Result type

Medtech innovation briefing

Published

15 March 2016

Evidence-based recommendations on procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay).

Result type

HealthTech guidance

Published

7 October 2015

Evidence-based recommendations on vamorolone (Agamree) for treating Duchenne muscular dystrophy in people 4 years and over.

Result type

Technology appraisal guidance

Published

16 January 2025

Discontinued Reference number: GID-TA10105

Result type

Technology appraisal guidance

Status

Discontinued

NICE has developed a medtech innovation briefing (MIB) on AI technologies for detecting diabetic retinopathy .

Result type

Medtech innovation briefing

Published

6 July 2021

for admission to an intensive care unit (ICU). The most commonly used medication is phenytoin. This should be used with...

Result type

Research recommendation

Published

13 August 2021

Evidence-based recommendations on ravulizumab (Ultomiris) for treating paroxysmal nocturnal haemoglobinuria in adults.

Result type

Technology appraisal guidance

Published

19 May 2021

Evidence-based recommendations on ibrutinib (Imbruvica) for treating relapsed or refractory mantle cell lymphoma in adults.

Result type

Technology appraisal guidance

Published

31 January 2018